INHALE: Investigation of Health outcomes in Australian Lung cancer

Abstract

The purpose of this study is to collect and analyse how lung cancer is managed in Australia, and examine patient outcomes. Who is it for? You may be eligible to join this study if you are aged 18 years or above and have been diagnosed with lung cancer. Study details: Participants in this study will continue to receive routine clinical care, which will not be impacted by involvement in this study. All enrolled patients will have clinical data collected for up to 5 years. Data captured will include presentation of the disease, surgical interventions, prescription of system therapies, and information regarding multidisciplinary management and outcomes of lung cancer in the routine clinical practice setting. This registry will be used to help to describe the current practice patterns so that we can continue to improve the health outcomes of patients diagnosed with lung cancer in Australia.